Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | ACE | P12821 | 3/20 | 0.55 |
| ▸ | FPR2 | P25090 | 1/20 | 0.54 |
| ▸ | ITGB2 | P05107 | 4/20 | 0.53 |
| ▸ | ICAM1 | P05362 | 4/20 | 0.53 |
| ▸ | ITGAL | P20701 | 4/20 | 0.53 |
| ▸ | NMBR | P28336 | 2/20 | 0.52 |
| ▸ | MDM4 | O15151 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | ECE1 | P42892 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL119372 | 1.00 | ALOX15 (0.56) | ALOX15ACEFPR2ITGB2ICAM1 | |
| SCHEMBL29350138 | 1.00 | ALOX15 (0.56) | ALOX15ACEFPR2ITGB2ICAM1 | |
| SCHEMBL29417397 | 1.00 | ALOX15 (0.56) | ALOX15ACEFPR2ITGB2ICAM1 | |
| SCHEMBL29350130 | 1.00 | ALOX15 (0.56) | ALOX15ACEFPR2ITGB2ICAM1 | |
| SCHEMBL850319 | 1.00 | ALOX15 (0.56) | ALOX15ACEFPR2ITGB2ICAM1 | |
| Water SCHEMBL6022940 | 0.99 | ALOX15 (0.55) | ALOX15ACEFPR2ITGB2ICAM1 | |
| Fluoride SCHEMBL7154596 | 0.99 | ALOX15 (0.55) | ALOX15ACEFPR2ITGB2ICAM1 | |
| SCHEMBL29903356 | 0.93 | NMBR (0.55) | ACENMBRECE1 | |
| SCHEMBL29903302 | 0.93 | NMBR (0.55) | ACENMBRECE1 | |
| SCHEMBL30310986 | 0.93 | ACE (0.53) | ACEECE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113666861-A | Preparation method of non-natural L-tryptophan derivative | 长兴宜生药物科技有限公司 | 2021-11-19 | — | — | CN | claimed |
| US-20240024266-A1 | Therapeutic Agent or Prophylactic Agent for COVID-19 | HIROSHIMA UNIVERSITY (JP) | 2024-01-25 | — | — | US | disclosed |
| CN-110475785-B | Peptide compound, method for producing same, composition for screening, and method for selecting peptide compound | 富士胶片株式会社 | 2023-06-13 | — | — | CN | disclosed |
| US-11319347-B2 | Peptide compound and method for producing same, composition for screening use, and method for selecting peptide compound | FUJIFILM CORPORATION (JP) | 2022-05-03 | — | — | US | disclosed |
| CN-113666861-A | Preparation method of non-natural L-tryptophan derivative | 长兴宜生药物科技有限公司 | 2021-11-19 | — | — | CN | disclosed |
| US-20200040039-A1 | PEPTIDE COMPOUND AND METHOD FOR PRODUCING SAME, COMPOSITION FOR SCREENING USE, AND METHOD FOR SELECTING PEPTIDE COMPOUND | FUJIFILM CORPORATION (JP) | 2020-02-06 | — | — | US | disclosed |
| EP-3604326-A1 | PEPTIDE COMPOUND AND METHOD FOR PRODUCING SAME, COMPOSITION FOR SCREENING USE, AND METHOD FOR SELECTING PEPTIDE COMPOUND | FUJIFILM Corporation (JP) | 2020-02-05 | — | — | EP | disclosed |
| US-9257576-B2 | Amino acid generator and polysiloxane composition containing the same | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-02-09 | — | — | US | disclosed |
| US-8895231-B2 | Patterning process and resist composition | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-11-25 | — | — | US | disclosed |
| US-8895231-B2 | Patterning process and resist composition | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-11-25 | — | — | US | disclosed |
| US-6329389-B1 | HETEROCYCLIC AMINES AND DERIVATIVES, SOMATOSTATIN AND ANTIDIABETIC AGENTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2001-12-11 | — | — | US | disclosed |
| EP-1070054-A1 | AMINE COMPOUNDS, THEIR PRODUCTION AND THEIR USE AS SOMATOSTATIN RECEPTOR ANTAGONISTS OR AGONISTS | Takeda Chemical Industries, Ltd. (JP) | 2001-01-24 | — | — | EP | disclosed |
| US-5985241-A | DIAGNOSTIC AND RADIODIAGNOSTIC AGENTS, FORMED BY REACTING TECHNETIUM-99M WITH A SOMATOSTATIN RECEPTOR-BINDING PEPTIDE | DIATIDE, INC. (US) | 1999-11-16 | — | — | US | disclosed |
| US-5981477-A | ADMINISTERING TO THE MAMMAL BEARING SOMATOSTATIN RECEPTOR EXPRESSING TUMOR, A METAL ION COMPLEXED SOMATOSTATIN RECEPTOR BINDING CYCLIC PEPTIDE | DIATIDE, INC. (US) | 1999-11-09 | — | — | US | disclosed |
| US-5972308-A | REACTING TECHNETIUM-99 WITH A CYCLIC OLIGOPEPTIDE HAVING AMINO ACID UNITS CONTAINING A MERCAPTAN GROUP ATTACHED TO THE RING THROUGH A HOMOCYSTEINE UNIT. | DIATIDE, INC. (US) | 1999-10-26 | — | — | US | disclosed |
| WO-1999052875-A1 | AMINE COMPOUNDS, THEIR PRODUCTION AND THEIR USE AS SOMATOSTATIN RECEPTOR ANTAGONISTS OR AGONISTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1999-10-21 | — | — | WO | disclosed |
| US-5965108-A | CYCLIC PEPTIDE-METAL COMPLEX SPECIFICALLY BINDS TO SURFACE SOMATOSTATIN RECEPTOR-EXPRESSING CELLS; RADIOLOGY; SCINTIGRAPHY; ANTITUMOR,-CARCINOGENIC AND METASTATIC AGENTS; STABILITY | DIATIDE, INC. (US) | 1999-10-12 | — | — | US | disclosed |
| US-5783170-A | Peptide-metal chelate conjugates | DIATIDE, INC. (US) | 1998-07-21 | — | — | US | disclosed |
| EP-0759786-A1 | SOMATOSTATIN BINDING PEPTIDE-METAL CHELATE CONJUGATES | DIATECH, INC. (US) | 1997-03-05 | — | — | EP | disclosed |
| WO-1995031221-A1 | SOMATOSTATIN BINDING PEPTIDE-METAL CHELATE CONJUGATES | DIATECH, INC. (US) | 1995-11-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200040039-A1 | PEPTIDE COMPOUND AND METHOD FOR PRODUCING SAME, COMPOSITION FOR SCREENING USE, AND METHOD FOR SELECTING PEPTIDE COMPOUND | VIP, NPPA, NGLY1 | ALOX15 3092/4885ACE 1959/4885FPR2 383/4885 |
| US-11319347-B2 | Peptide compound and method for producing same, composition for screening use, and method for selecting peptide compound | VIP, NPPA, NGLY1 | ALOX15 3092/4885ACE 1959/4885FPR2 383/4885 |
| US-20240024266-A1 | Therapeutic Agent or Prophylactic Agent for COVID-19 | PIN1, ACE2, ACE | ALOX15 1083/4885ACE 3/4885FPR2 2579/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.